232 related articles for article (PubMed ID: 34710844)
1. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Fathi M; Bahmanpour S; Barshidi A; Rasouli H; Karoon Kiani F; Mahmoud Salehi Khesht A; Izadi S; Rashidi B; Kermanpour S; Mokhtarian R; Karpisheh V; Hassannia H; Mohammadi H; Jalili A; Jadidi-Niaragh F
Int Immunopharmacol; 2021 Dec; 101(Pt A):108288. PubMed ID: 34710844
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.
Karpisheh V; Fakkari Afjadi J; Nabi Afjadi M; Haeri MS; Abdpoor Sough TS; Heydarzadeh Asl S; Edalati M; Atyabi F; Masjedi A; Hajizadeh F; Izadi S; Mirzazadeh Tekie FS; Hajiramezanali M; Sojoodi M; Jadidi-Niaragh F
Int J Biol Macromol; 2021 Jan; 167():1006-1019. PubMed ID: 33227333
[TBL] [Abstract][Full Text] [Related]
3. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
Izadi S; Moslehi A; Kheiry H; Karoon Kiani F; Ahmadi A; Masjedi A; Ghani S; Rafiee B; Karpisheh V; Hajizadeh F; Atyabi F; Assali A; Mirzazadeh Tekie FS; Namdar A; Ghalamfarsa G; Sojoodi M; Jadidi-Niaragh F
Pharm Res; 2020 Sep; 37(10):196. PubMed ID: 32944844
[TBL] [Abstract][Full Text] [Related]
4. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.
Budi HS; Izadi S; Timoshin A; Asl SH; Beyzai B; Ghaderpour A; Alian F; Eshaghi FS; Mousavi SM; Rafiee B; Nikkhoo A; Ahmadi A; Hassannia H; Ahmadi M; Sojoodi M; Jadidi-Niaragh F
Nanomedicine; 2021 Jun; 34():102373. PubMed ID: 33667724
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression.
Hajizadeh F; Moghadaszadeh Ardebili S; Baghi Moornani M; Masjedi A; Atyabi F; Kiani M; Namdar A; Karpisheh V; Izadi S; Baradaran B; Azizi G; Ghalamfarsa G; Sabz G; Yousefi M; Jadidi-Niaragh F
Eur J Pharmacol; 2020 Sep; 882():173235. PubMed ID: 32574672
[TBL] [Abstract][Full Text] [Related]
6. CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
Liu L; You X; Han S; Sun Y; Zhang J; Zhang Y
Oncol Rep; 2021 Mar; 45(3):835-845. PubMed ID: 33469677
[TBL] [Abstract][Full Text] [Related]
7. Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
Zhou X; Du J; Wang H; Chen C; Jiao L; Cheng X; Zhou X; Chen S; Gou S; Zhao W; Zhai W; Chen J; Gao Y
Cell Commun Signal; 2020 Sep; 18(1):142. PubMed ID: 32894141
[TBL] [Abstract][Full Text] [Related]
8. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
10. TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer.
Chen Y; Huang H; Li Y; Xiao W; Liu Y; Chen R; Zhu Y; Zheng X; Wu C; Chen L
Front Immunol; 2022; 13():832230. PubMed ID: 35320940
[TBL] [Abstract][Full Text] [Related]
11. TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer.
Ge Z; Peppelenbosch MP; Sprengers D; Kwekkeboom J
Front Immunol; 2021; 12():699895. PubMed ID: 34367161
[TBL] [Abstract][Full Text] [Related]
12. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
13. TOX-expressing terminally exhausted tumor-infiltrating CD8
Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
[TBL] [Abstract][Full Text] [Related]
14. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L
Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
17. TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism.
Shao Q; Wang L; Yuan M; Jin X; Chen Z; Wu C
Front Immunol; 2021; 12():688961. PubMed ID: 34659197
[TBL] [Abstract][Full Text] [Related]
18. Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation.
Han JH; Cai M; Grein J; Perera S; Wang H; Bigler M; Ueda R; Rosahl TW; Pinheiro E; LaFace D; Seghezzi W; Williams SMG
Front Immunol; 2020; 11():573405. PubMed ID: 33117369
[TBL] [Abstract][Full Text] [Related]
19. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.
He G; Pan X; Liu X; Zhu Y; Ma Y; Du C; Liu X; Mao C
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48296-48309. PubMed ID: 33054172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]